These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 32201366)

  • 21. The de novo synthesis of ubiquitin: identification of deubiquitinases acting on ubiquitin precursors.
    Grou CP; Pinto MP; Mendes AV; Domingues P; Azevedo JE
    Sci Rep; 2015 Aug; 5():12836. PubMed ID: 26235645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune Evasion and Drug Resistance Mediated by USP22 in Cancer: Novel Targets and Mechanisms.
    Guo J; Zhao J; Fu W; Xu Q; Huang D
    Front Immunol; 2022; 13():918314. PubMed ID: 35935969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ubiquitin becomes ubiquitous in cancer: emerging roles of ubiquitin ligases and deubiquitinases in tumorigenesis and as therapeutic targets.
    Shi D; Grossman SR
    Cancer Biol Ther; 2010 Oct; 10(8):737-47. PubMed ID: 20930542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deubiquitinases in cancer.
    Dewson G; Eichhorn PJA; Komander D
    Nat Rev Cancer; 2023 Dec; 23(12):842-862. PubMed ID: 37935888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impressionist portraits of mitotic exit: APC/C, K11-linked ubiquitin chains and Cezanne.
    Bonacci T; Emanuele MJ
    Cell Cycle; 2019; 18(6-7):652-660. PubMed ID: 30874463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging role of DUBs in tumor metastasis and apoptosis: Therapeutic implication.
    He M; Zhou Z; Wu G; Chen Q; Wan Y
    Pharmacol Ther; 2017 Sep; 177():96-107. PubMed ID: 28279784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemical biology tools to study Deubiquitinases and Ubl proteases.
    Gorka M; Magnussen HM; Kulathu Y
    Semin Cell Dev Biol; 2022 Dec; 132():86-96. PubMed ID: 35216867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-stabilizing regulation of deubiquitinating enzymes in an enzymatic activity-dependent manner.
    Hou Z; Shi W; Feng J; Wang W; Zheng E; Lin H; Yu C; Li L
    Int J Biol Macromol; 2021 Jun; 181():1081-1091. PubMed ID: 33864866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of pluripotency and differentiation by deubiquitinating enzymes.
    Suresh B; Lee J; Kim H; Ramakrishna S
    Cell Death Differ; 2016 Aug; 23(8):1257-64. PubMed ID: 27285106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deubiquitinases: Modulators of Different Types of Regulated Cell Death.
    Lee CS; Kim S; Hwang G; Song J
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of USP7 upregulates USP22 and activates its downstream cancer-related signaling pathways in human cancer cells.
    Zhang K; Sun T; Li W; Guo Y; Li A; Hsieh M; Wang J; Wu J; Arvanitis L; Raz DJ
    Cell Commun Signal; 2023 Nov; 21(1):319. PubMed ID: 37946202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deubiquitinating enzymes (DUBs): Regulation, homeostasis, and oxidative stress response.
    Snyder NA; Silva GM
    J Biol Chem; 2021 Sep; 297(3):101077. PubMed ID: 34391779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deubiquitinases and the new therapeutic opportunities offered to cancer.
    Pfoh R; Lacdao IK; Saridakis V
    Endocr Relat Cancer; 2015 Feb; 22(1):T35-54. PubMed ID: 25605410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breaking the chains: deubiquitylating enzyme specificity begets function.
    Clague MJ; Urbé S; Komander D
    Nat Rev Mol Cell Biol; 2019 Jun; 20(6):338-352. PubMed ID: 30733604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plant deubiquitinases: from structure and activity to biological functions.
    Luo R; Yang K; Xiao W
    Plant Cell Rep; 2023 Mar; 42(3):469-486. PubMed ID: 36567335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.
    Sun SC
    Cell Death Differ; 2010 Jan; 17(1):25-34. PubMed ID: 19373246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deubiquitinases: From mechanisms to their inhibition by small molecules.
    Lange SM; Armstrong LA; Kulathu Y
    Mol Cell; 2022 Jan; 82(1):15-29. PubMed ID: 34813758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of E3 Ligases and Deubiquitinases in the Control of HIF-α Subunit Abundance.
    Kubaichuk K; Kietzmann T
    Cells; 2019 Jun; 8(6):. PubMed ID: 31208103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular functions, molecular signalings and therapeutic applications: Translational potential of deubiquitylating enzyme USP9X as a drug target in cancer treatment.
    Gao H; Chen Z; Zhao L; Ji C; Xing F
    Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189099. PubMed ID: 38582329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioinformatical Approaches to the Discovery and Classification of Novel Deubiquitinases.
    Hermanns T; Hofmann K
    Methods Mol Biol; 2023; 2591():135-149. PubMed ID: 36350547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.